Patents by Inventor Jeremy Wesley Gleaton

Jeremy Wesley Gleaton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11524051
    Abstract: Methods of treating a fungal infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a composition comprising one or more antifungal peptides selected from the group consisting of BmKn2, dBmKn2, Kn2-7, and dKn2-7 are described. Antifungal pharmaceutical compositions and dosage forms, including field-deployable dosage forms, comprising one or more of these antifungal peptides are also described.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: December 13, 2022
    Assignee: The United States of America as Represented by the Secretary of the Navy
    Inventors: Nancy Millenbaugh, Jeremy Wesley Gleaton, Dickson Kiprono Kirui, Sabrina Snyder, Crystal Rock
  • Patent number: 10946065
    Abstract: The invention relates to methods of treating a fungal infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a composition comprising one or more antifungal peptides selected from the group consisting of BmKn2, dBmKn2, Kn2-7, and dKn2-7. Antifungal pharmaceutical compositions and dosage forms, including field-deployable dosage forms, comprising one or more of these antifungal peptides are also contemplated herein.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: March 16, 2021
    Assignee: The United States of America, as Represented by the Secretary of the Navy
    Inventors: Nancy Millenbaugh, Jeremy Wesley Gleaton, Dickson Kiprono Kirui
  • Publication number: 20200397862
    Abstract: The invention relates to methods of treating a fungal infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a composition comprising one or more antifungal peptides selected from the group consisting of BmKn2, dBmKn2, Kn2-7, and dKn2-7. Antifungal pharmaceutical compositions and dosage forms, including field-deployable dosage forms, comprising one or more of these antifungal peptides are also contemplated herein.
    Type: Application
    Filed: September 3, 2020
    Publication date: December 24, 2020
    Applicant: United States of America as represented by the Secretary of the Navy
    Inventors: Nancy Millenbaugh, Jeremy Wesley Gleaton, Dickson Kiprono Kirui, Sabrina Snyder, Crystal Rock
  • Publication number: 20200108121
    Abstract: The invention relates to methods of treating a fungal infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a composition comprising one or more antifungal peptides selected from the group consisting of BmKn2, dBmKn2, Kn2-7, and dKn2-7. Antifungal pharmaceutical compositions and dosage forms, including field-deployable dosage forms, comprising one or more of these antifungal peptides are also contemplated herein.
    Type: Application
    Filed: December 17, 2019
    Publication date: April 9, 2020
    Applicant: United States of America as represented by the Secretary of the Navy
    Inventors: Nancy Millenbaugh, Jeremy Wesley Gleaton, Dickson Kiprono Kirui
  • Patent number: 10548948
    Abstract: Antifungal pharmaceutical compositions, dosage forms, and methods of use thereof are disclosed.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: February 4, 2020
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Nancy Millenbaugh, Jeremy Wesley Gleaton, Dickson Kiprono Kirui
  • Publication number: 20180250362
    Abstract: The invention relates to methods of treating a fungal infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a composition comprising one or more antifungal peptides selected from the group consisting of BmKn2, dBmKn2, Kn2-7, and dKn2-7. Antifungal pharmaceutical compositions and dosage forms, including field-deployable dosage forms, comprising one or more of these antifungal peptides are also contemplated herein.
    Type: Application
    Filed: February 27, 2018
    Publication date: September 6, 2018
    Applicant: United States of America as represented by the Secretary of the Navy
    Inventors: Nancy Millenbaugh, Jeremy Wesley Gleaton, Dickson Kiprono Kirui